Guanfacine Hydrochloride

盐酸胍法辛

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameGuanfacine Hydrochloride
Drug Alias Nameguanfacinum盐酸谷氨法新胍法辛盐酸盐guanfacina盐酸胍法新 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsSchizotypal Personality DisorderAttention Deficit Disorder with HyperactivityCognition Disorders +[19] 
Global Approved IndicationsAttention Deficit Disorder with HyperactivityHypertension
Approved Indications in ChinaAttention Deficit Disorder with Hyperactivity
Original Approved Country/TerritoryUnited States
Original Approved Date1986/10/27
Country/TerritoryBelgiumCanadaUnited States +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPromius Pharma
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals USA IncTakeda Pharmaceuticals International AG Ireland BranchYale University +[10] 
Inactive CompaniesShireMaastricht University Medical CenterIcahn School Of Medicine At Mount Sinai +[7] 
Active IndicationsAttention Deficit Disorder with HyperactivityCognition DisordersMarijuana Use +[8] 
Inactive IndicationsSchizotypal Personality DisorderPhobia, SocialAnxiety, Separation +[11] 

Other Information

ATC CodeC02AC02
Related LinksWikipediaDrugBankKEGG